This is an eye condition that happens in people with Graves disease, an autoimmune thyroid problem. It causes swelling and inflammation in the tissues around your eyes. Sometimes it affects the muscles that move your eyes, making them feel stuck or double. It's important to see a doctor if you have this.
Every report comes from a Lived member, sent anonymously.
Have you tried Lubricant Eye Drops for Graves Eye Disease?
Graves eye disease, also called thyroid eye disease, is an autoimmune condition in which the immune system inflames the muscles and fatty tissue that sit behind and around the eyes. It most often affects people with Graves disease, the autoimmune cause of an overactive thyroid. About one in three people with Graves disease notice eye symptoms, usually within the first year or so after the thyroid problem is diagnosed. Because the eye sits in a rigid bony socket, swelling behind it has nowhere to go except forward. That explains the most recognizable signs: eyes that bulge or look staring, upper eyelids pulled back so more white shows, puffy or red lids, and gritty, dry or watery eyes that are sensitive to light. When the swollen muscles stiffen, the eyes may stop moving together, causing double vision. Both eyes are usually affected, though often unevenly. Most cases are mild. In a small minority, swelling presses on the optic nerve (the nerve that carries vision from the eye to the brain), or the lids can no longer close enough to protect the surface of the eye. These are the forms that can threaten sight.
The same antibodies that overstimulate the thyroid in Graves disease also act on tissue behind the eyes, setting off inflammation and the buildup of fat and fluid there. Less often, the eye disease occurs with Hashimoto's thyroiditis (an autoimmune cause of an underactive thyroid) or in people whose thyroid levels are normal. Smoking is the strongest risk factor people can change. It makes the eye disease more likely to start and more likely to be severe, and secondhand smoke counts too. Thyroid levels that stay too high or swing too low can also worsen the eyes, as can treating an overactive thyroid with radioactive iodine. Women develop Graves eye disease more often, but men, people over 50 and people with diabetes are more likely to have severe forms. None of this means a person caused their own eye disease; it reflects how the immune system responds.
In someone with Graves disease, the diagnosis usually comes from the symptoms and an eye examination, alongside blood tests that confirm the thyroid condition, including thyroid antibody tests. A thyroid specialist or primary care clinician can often spot the early signs, but an ophthalmologist (eye doctor) is needed to check what matters most for vision: sharpness of sight, color vision, side vision, the optic nerve and the surface of the eye. Clinicians judge two separate things. Severity describes how much damage there is: how far the eyes protrude (measured in millimeters with a small ruler-like instrument), how well the lids close, and whether there is double vision. Activity describes whether inflammation is still ongoing, judged by pain, redness and swelling and often recorded as a clinical activity score. A score of 3 or more out of 7 at a first visit suggests the disease is active, which matters because treatments that calm inflammation work best during this phase. Detailed imaging of the eye sockets, with a CT (computed tomography) or MRI (magnetic resonance imaging) scan, is not always needed. It is used when the picture is unusual, such as one eye affected without clear thyroid disease, when the optic nerve may be compressed, or before surgery.
Two steps help almost everyone. The first is quitting smoking and avoiding smoke. The second is bringing thyroid levels into the normal range and keeping them there, because both overactive and underactive thyroid levels can make the eyes worse. This affects how the thyroid itself is treated: radioactive iodine can trigger or worsen the eye disease, so it is generally avoided when eye disease is active and moderate or severe, and a short course of a steroid such as prednisone may be given alongside it when the eye disease is mild. Mild disease is usually managed with eye care rather than strong medicines. Lubricating drops by day and a gel at night protect the eye surface, sunglasses ease light sensitivity, raising the head of the bed can reduce morning puffiness, and glasses with prisms can help with mild double vision. A six-month course of the mineral selenium may help mild, active disease, mainly in regions where people tend to be low in selenium. Active disease that is moderate to severe calls for medicine to calm the inflammation. Steroids given through a vein (intravenous methylprednisolone) are a long-standing first choice. They reduce pain, redness and swelling, but have only a small effect on bulging, and side effects such as raised blood sugar, mood or sleep changes and higher blood pressure need monitoring. Teprotumumab (Tepezza) is an antibody medicine that blocks a growth signal driving the swelling behind the eye. It is given as eight infusions three weeks apart and is the most effective medicine for reducing bulging and double vision, though about a third of people lose some of the improvement within a year. Its main trade-offs are hearing problems, including hearing loss that can be permanent, raised blood sugar, and harm to an unborn baby, so it is not used in pregnancy. There are no trials directly comparing it with steroid infusions, and the choice depends on which eye problems matter most, other health conditions, cost and access. Other options, such as radiation treatment to the eye sockets or other immune-modifying medicines, are used in selected cases. Surgery repairs lasting changes once the disease has been stable for several months. It is done in stages as needed: orbital decompression (removing some bone or fat to give the eye room to settle back), then eye muscle surgery for double vision, then eyelid surgery. Decompression can occasionally cause new double vision. When the optic nerve is being compressed, high-dose steroid infusions are given urgently, and decompression surgery is done promptly if vision does not recover.
Graves eye disease typically has an active phase of inflammation that lasts roughly six months to two years, during which symptoms may come and go and can worsen. It then settles into an inactive phase in which the eyes stop changing. Some improvement often happens on its own, but bulging, eyelid position or double vision may not return fully to how they were. A minority of people have a later flare, most often within the first five years. During the active phase, regular checks with both the thyroid team and an eye specialist track activity and severity, so treatment can start while it is most effective. People with moderate or severe disease are often cared for at a specialist thyroid eye clinic. Daily life can be affected by sore, dry eyes, light sensitivity, double vision that makes reading or driving harder, and changes in appearance that many people find distressing. These effects on confidence and mood are real and worth raising with the care team. For those who need surgery, the staged operations happen over months once the disease has settled.
If you have Graves disease or another thyroid condition and notice gritty or red eyes, puffy lids, eyes that look more prominent, or double vision, ask for an eye examination at your next opportunity rather than waiting for symptoms to settle. Contact your eye doctor or thyroid team the same day if your vision becomes blurred or dim, colors look washed out, or parts of your vision seem missing, since these can mean the optic nerve is being compressed and delays risk permanent vision loss. The same applies if your eyelids can no longer close over your eyes, or if eye pain, redness and light sensitivity are rapidly getting worse, which can mean the surface of the eye is being damaged.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Graves Eye Disease is like, what's helped you, or ask the community a question.